VNDA
Vanda Pharmaceuticals Inc.
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$7.60
$-0.45
(-5.59%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $449.13M | EPS (ttm) | $-1.44 | Current Price | $7.60 |
| Enterprise Value | $166.30M | Forward EPS | $0.20 | Previous Close | $8.05 |
| P/E Ratio | - | ROA | -12.15% | 52W High | $9.60 |
| Forward P/E | 38.00 | ROE | -16.72% | 52W Low | $3.81 |
| PEG Ratio | - | Gross Margin | 94.44% | 50 Day Avg | $6.87 |
| P/S Ratio | 2.12 | Operating Margin | -55.61% | 200 Day Avg | $5.20 |
| P/B Ratio | 0.96 | Profit Margin | -39.70% | Volume | 1.03M |
| EV/EBITDA | -1.47 | Current Ratio | 3.12 | Avg Volume | 1.69M |
| EV/Sales | 0.78 | Quick Ratio | 2.92 | Beta | 0.58 |
| Employees | 368.00 | Debt/Equity | 2.34 | Shares Outstanding | 59.10M |
| Sector | Healthcare | Total Debt | $10.91M | Float Shares | 52.58M |
| Industry | Biotechnology | Total Cash | $293.75M | Short Float | 5.06% |
| Optionable | - | Cash/Share | $4.97 | Short Ratio | 1.01 |
| Dividend Yield | - | Book Value/Share | $7.89 | % Held by Insiders | 7.21% |
| Target Price | $13.62 | Revenue (TTM) | $212.07M | % Held by Institutions | 74.99% |